These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7961162)

  • 1. Effect of conagenin on thrombocytopenia induced by antitumor agents in mice.
    Kawatsu M; Yamashita T; Ishizuka M; Takeuchi T
    J Antibiot (Tokyo); 1994 Oct; 47(10):1123-9. PubMed ID: 7961162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of efficacy of antitumor agents by conagenin.
    Kawatsu M; Yamashita T; Ishizuka M; Takeuchi T
    J Antibiot (Tokyo); 1995 Mar; 48(3):222-5. PubMed ID: 7730156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation by conagenin of inflammatory mediator productions in mice given 5-fluorouracil.
    Kawatsu M; Yamashita T; Ishizuka M; Takeuchi T
    Anticancer Res; 1997; 17(2A):917-22. PubMed ID: 9137428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of conagenin in tumor bearing mice. Antitumor activity, generation of effector cells and cytokine production.
    Kawatsu M; Yamashita T; Osono M; Masuda T; Ishizuka M; Takeuchi T
    J Antibiot (Tokyo); 1993 Nov; 46(11):1692-8. PubMed ID: 8270491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of intestinal toxicity of 5-fluorouracil by conagenin, a low molecular immunomodulator.
    Kawatsu M; Yamashita T; Ishizuka M; Takeuchi T
    Anticancer Res; 1996; 16(5A):2937-41. PubMed ID: 8917410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell activation by conagenin in mice.
    Kawatsu M; Yamashita T; Osono M; Ishizuka M; Takeuchi T
    J Antibiot (Tokyo); 1993 Nov; 46(11):1687-91. PubMed ID: 8270490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of (+)-catechin against 5-fluorouracil-induced myelosuppression in mice.
    Takano F; Tanaka T; Aoi J; Yahagi N; Fushiya S
    Toxicology; 2004 Sep; 201(1-3):133-42. PubMed ID: 15297028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelophil, a mixture of Astragali Radix and Salviae Radix extract, moderates toxic side effects of fluorouracil in mice.
    Shin JW; Lee MM; Son JY; Lee NH; Cho CK; Chung WK; Cho JH; Son CG
    World J Gastroenterol; 2008 Apr; 14(15):2323-8. PubMed ID: 18416457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human interleukin-11 improved carboplatin-induced thrombocytopenia without affecting antitumor activities in mice bearing Lewis lung carcinoma cells.
    Saitoh M; Taguchi K; Momose K; Suga K; Yamazaki N; Ono C; Suzuki T; Takeuchi O; Yasuda S; Miyata K
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):161-6. PubMed ID: 11862431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombocytopenia in association with splenomegaly during granulocyte-colony-stimulating factor treatment in mice is not caused by hypersplenism and is resolved spontaneously.
    Takamatsu Y; Jimi S; Sato T; Hara S; Suzumiya J; Tamura K
    Transfusion; 2007 Jan; 47(1):41-9. PubMed ID: 17207228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombopoietic activity of recombinant human interleukin-11 in nonhuman primates with ACNU-induced thrombocytopenia.
    Saitoh M; Taguchi K; Yasuda S; Kikumori M; Nishimori T; Suda M; Okamiya H; Usuda S; Miyata K
    J Interferon Cytokine Res; 2000 Jun; 20(6):539-45. PubMed ID: 10888110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined interleukin 1 beta/interleukin 2 treatment in mice: synergistic myelostimulatory activity and protection against cyclophosphamide-induced myelosuppression.
    Proietti E; Tritarelli E; Gabriele L; Testa U; Greco G; Pelosi E; Gabbianelli M; Belardelli F; Peschle C
    Cancer Res; 1993 Feb; 53(3):569-76. PubMed ID: 8425189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined interleukin-1 beta/interleukin-6 treatment in mice: synergistic myelostimulatory activity and myelorestorative effect after cyclophosphamide-induced myelosuppression.
    Tritarelli E; Greco G; Testa U; Belardelli F; Peschle C; Proietti E
    Cancer Res; 1994 Dec; 54(24):6469-76. PubMed ID: 7987845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of recombinant human leukemia inhibitory factor against thrombocytopenia in carboplatin-treated mice.
    Akiyama Y; Kikuchi Y; Matsuzaki J; Kajimura N; Ohue C; Yamaguchi K
    Jpn J Cancer Res; 1997 Jun; 88(6):584-9. PubMed ID: 9263536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effects of co-administration of angiotensin 1-7 and Neupogen on hematopoietic recovery in mice.
    Ellefson DD; diZerega GS; Espinoza T; Roda N; Maldonado S; Rodgers KE
    Cancer Chemother Pharmacol; 2004 Jan; 53(1):15-24. PubMed ID: 14569417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombocytopoietic Efficacy of Pegylated Recombinant Human Interleukin-11 Mutein in Myelosuppressed Mice].
    Ma SS; Ho SH; Wang HL; Nie LY; Xu SS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1511-1517. PubMed ID: 27784384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of granulocyte colony-stimulating factor on hematopoietic injury induced by anticancer drugs in mice.
    Mizushima Y; Morikage T; Kuwahara T; Yano S
    J Biol Response Mod; 1990 Dec; 9(6):576-83. PubMed ID: 1705961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of acute chemotherapy-induced death in mice by recombinant human interleukin 1: protection from hematological and nonhematological toxicities.
    Damia G; Komschlies KL; Futami H; Back T; Gruys ME; Longo DL; Keller JR; Ruscetti FW; Wiltrout RH
    Cancer Res; 1992 Aug; 52(15):4082-9. PubMed ID: 1638519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential administration of the high affinity CXCR4 antagonist BKT140 promotes megakaryopoiesis and platelet production.
    Abraham M; Weiss ID; Wald H; Wald O; Nagler A; Beider K; Eizenberg O; Peled A
    Br J Haematol; 2013 Oct; 163(2):248-59. PubMed ID: 23906028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Impedance effects of interleukin-6 on cyclophosphamide-induced hematopoietic damnification in dogs].
    Yin H; He X; Bao X; Liu X; Yang G
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2005 Aug; 22(4):798-801. PubMed ID: 16156276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.